Epidermodysplasia verruciformis: clinical regression and increased cellular immunity induced by OK 432 treatment.
D000328:Adult; D001688:Biological Products / Q000627:therapeutic use*; D006801:Humans; D007111:Immunity, Cellular; D008297:Male; D010844:Picibanil / Q000627:therapeutic use*; D012871:Skin Diseases / Q000276:immunology / Q000628:therapy*; D014860:Warts / Q000276:immunology / Q000628:therapy*
D001688:Biological Products; D010844:Picibanil